Press release content from Business Wire. The AP news staff was not involved in its creation.

joimax® Announces Executive Appointments Among Record-Breaking Sales for 2022

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 5, 2023 GMT

KARLSRUHE, Germany--(BUSINESS WIRE)--Jan 5, 2023--

joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has appointed Mr. Maximilian Ries and Mr. Anthony Troncale to new executive positions, effective January 1. The announcement comes among record-breaking sales across Europe, Asia, and the United States in 2022.

Ries took on the newly created role of Executive Vice President, Business Development and Operations at joimax®. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax® continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax®, Ries built out the United States and Latin American markets.

Troncale was promoted to General Manager; he was formerly Vice President of Marketing and Business Development at joimax® Inc. Over the past two years, Troncale, in addition to increasing his responsibilities, successfully capitalized on the significant interest in endoscopic techniques to expand US sales operations. He joined joimax® in 2021 bringing 20-years of experience in the spinal device industry where he served in sales and marketing leadership roles at Stryker, K2M, and Synthes Spine.

Contributing to the global organization’s continuous strong sales growth was the launch of a new surgical access system, “Tessys® Trans SAP” and the global expansion of the ESPINEA® Education Academy.

“I am extremely pleased with our 2022 global performance and the significant interest in endoscopic spine surgery,” stated joimax® Founder and CEO Wolfgang Ries. “With Max and Tony in their new roles, our market-leading endoscopic spine technologies, and our anticipated launch of two more new surgical access systems later in 2023, we are well positioned for another very successful year.”

Aboutjoimax®

Founded in Karlsruhe, Germany, in 2001, joimax ® is the leading developer and marketer of complete systems for full-endoscopic and minimally invasive spinal surgery. With the Endoscopic Surgical Systems TESSYS ® (transforaminal), iLESSYS ® (interlaminar) and CESSYS ® (cervical) for decompression procedures, MultiZYTE ® for facet and sacroiliac joint pain treatment, EndoLIF ® and Percusys ® for minimally-invasive endoscopically assisted stabilizations, established systems are provided, addressing a whole range of indications. All methods are supported by the latest generation electronical devices in the all new NAVENTO ® navigated endoscopic tower. In procedures for herniated disc, stenosis, pain therapy or spinal stabilization treatment, surgeons utilize joimax ® technologies to operate through small incisions under local or full anesthesia, via tissue and muscle-sparing corridors and through natural openings in the spinal canal, e.g. the intervertebral foramen, the so-called “Kambin triangle”.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230105005905/en/

CONTACT: Press Contact Germany

joimax® GmbH

Susanne Schmidinger

susanne.schmidinger@joimax.com

+49-721-25514-0Press Contact USA

joimax®, Inc.

Emma Gartner

emma.gartner@joimaxusa.com

+1-949-859-3472

KEYWORD: CALIFORNIA GERMANY EUROPE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SURGERY MEDICAL DEVICES HOSPITALS HEALTH HEALTH TECHNOLOGY

SOURCE: joimax

Copyright Business Wire 2023.

PUB: 01/05/2023 02:11 PM/DISC: 01/05/2023 02:11 PM

http://www.businesswire.com/news/home/20230105005905/en